PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
inhibin and activin |
|
|
|
Related
|
|
Insufficient production of inhibin alpha and possibly beta(A)-subunits,but not follistatin,is associated with follicular arrest in PCOS follicles |
|
|
|
|
|
Direct
|
130 PCOS and 120 controls |
Methylation levels of CpG sites in theFST promoter and 5'-UTR are not associated with PCOS |
|
|
|
|
Rotterdam criteria |
Related
|
Indian population (250 PCOS and 299 controls) |
Exonic variants of FST gene seems to be dependent on the subjects and its role in the PCOS pathophysiology cannot be established |
|
Androgen |
|
|
Rotterdam criteria |
Related
|
239 PCOS and 38 control |
High myostatin level was associated with the increased risk of abdominal obesity after further adjusting the androgens and follistatin levels in women with PCOS |
|
hsCRP |
|
|
Rotterdam criteria |
Related
|
Taiwanese population (155 PCOS and 37 controls) |
Follistatin and hsCRP levels in both the PCOS and control groups were significantly correlated with each other |
|
|
|
SNP rs3797297 from FST |
NIH criteria |
Related
|
Caucasian population (173 PCOS and 107 control) |
SNP rs3797297 from FST gene was associated with androgenic markers for PCOS |
|
|
|
|
|
Related
|
|
FS315 is indeed the major circulating FST isoform but is undetectable in follicular fluid samples aspirated from normal women or PCOS |
|
|
|
|
PCOS was defined by the presence of menstrual dysfunction, hirsutism (defined by a modified Ferriman-Gallwey score >7) with or without increased serum androgens, and exclusion of hyperprolactinemia, thyroid dysfunction, and nonclassic 21-hydroxylase defic |
Related
|
34 PCOS and 15control |
Mutations in the coding regions of the follistatin gene do not appear to be related to PCOS |
|
activin A and inhibin B |
|
|
Subjects with PCOS were identified by the presence of hyperandrogenaemia, polycystic ovaries on ultrasound and menstrual abnormalities with no recent ovulation as evidenced by progesterone concentrations. |
Related
|
108 PCOS and 20 controls |
Higher concentrations of follistatin with lower concentrations of activin A may relate to follicular development and may be partly responsible for the lack of pre-ovular follicle development in PCOS |
|
|
|
|
PCOS was defined by the presence of menstrual dysfunction, hirsutism (defined by a modified Ferriman-Gallwey score >7) with or without increased serum androgens, and exclusion of hyperprolactinemia, thyroid dysfunction, and nonclassic 21-hydroxylase defic |
Related
|
85 PCOS |
Etiology of PCOS from the follistatin gene, if any, are likely to be small. |
|
|
|
|
The diagnosis of PCOS was based on the clinical features and laboratory examination. |
Related
|
Chinese population (64 PCOS) |
PCOS in the local Chinese population is not caused by mutations in the coding regions of the follistatin gene |
|
|
|
|
An index case was considered affected if she met the following criteria: chronic menstrual irregularity (amenorrhea or six menses per year; ref.27) and hyperandrogenemia (HA), i.e., elevated levels of total testosterone or testosterone not bound to sex |
Related
|
37 PCOS |
The study shows how a systematic screen of candidate genes can provide strong evidence for genetic linkage in complex diseases and can identify those genes that should have high (or low) priority for further study. |
|
|
|
|
|
Related
|
|
Concentration of FSHin the micro-environment may not play a key role in the mechanisms of selection, atresia, and PCOS in women |
|
inhibin and activin |
|
|
|
Related
|
6 PCOS |
Granulosa cells of small antral follicles are less active in polycystic than in normal ovaries with respect to inhibin alpha-subunit and follistatin mRNA expression |
|
Activin |
PCOS |
|
NIH criteria an dnon-NIH criteria |
Related
|
Overweight and obese, premenopausal women with PCOS (n=51, n=26 National Institutes of Health (NIH) and n=25 non-NIH) and without PCOS (n=25 controls) |
Follistatin may potentially act as a marker of or be involved in the pathophysiology of both reproductive and metabolic features of PCOS. |